27-Nov-2007 - Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility.
22-Nov-2007 - FMC BioPolymer has introduced two new excipient products to the pharma market - the first in two years.
12-Nov-2007 - German chemicals firm BASF has announced a major price hike across its range of pharmaceutical excipients, upping price tags by as much as 9 per cent.
29-Oct-2007 - Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
23-Oct-2007 - Pfizer may have given up on its non-injectable insulin, but researchers in the US think they may have cracked a way to deliver the hormone orally, linking it up to vitamin B12 to protect it through the digestive system.
17-Oct-2007 - Growing demand has prompted tableting specialist Meldex International, formerly BioProgress, to launch a new sales and distribution hub in Germany, with the UK firm also announcing a new manufacturing contract for its XGel film.
12-Oct-2007 - In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry.
09-Oct-2007 - UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency.
04-Oct-2007 - Finland-based Atacama Labs has launched its proprietary technology system for developing solid oral dosage forms.
24-Sep-2007 - Novartis has announced its latest batch of thumbs up from EU regulators, potentially adding a few more products to its 'approved' list for this year.
18-Sep-2007 - UK researchers are developing 'green' methods of coating delicate biopharmaceutical drugs that reduce the risk of damaging the drugs while replacing the harsh solvents normally used in the process.
17-Sep-2007 - UK tabletting specialist BioProgress made a series of announcements last week, not only landing itself a commercial partner and patent protection for its novel tablet coating technology, but also rebranding itself under a new name, Meldex International.
10-Sep-2007 - Denmark-based Chr. Hansen has sold its excipients and coating division to US company Colorcon for an undisclosed sum to concentrate on its food business.
29-Aug-2007 - ALK-Abello will be funding a new DKK 300m (€40.3m) production line dedicated to its oral grass pollen allergy vaccine at Catalent Pharma Solutions' UK facility.
13-Aug-2007 - The lowest formulated dose of cholesterol-busting fenofibrate has been approved for the US market using a new formulation platform.
08-Aug-2007 - GPC Biotech announced its second quarter financial results this week, trying to put a brave face on its outlook despite the recent disappointments regarding its lead oral cancer drug.
06-Aug-2007 - German pharma firm Stada has acquired Russian pharmaceuticals group Makiz in a deal worth up to €135m, giving the company a sturdy foothold in the growing Russian market and enhanced in-house production capacity.
26-Jul-2007 - GPC Biotech was dealt a blow this week as an advisory committee recommended that regulatory bodies should hold off on approval of a novel oral formulation of a platinum-based cancer drug.
24-Jul-2007 - Roche has received a positive opinion from EU regulators recommending the approval of low-dose capsules of the blockbuster flu drug Tamiflu (oseltamivir), providing a more convenient dosage form for children.
12-Jul-2007 - University of Texas at Arlington (UTA) spin-out has exclusively licensed plasma coating technology that could improve the controlled release of drugs and the biocompatibility of medical implants.
11-Jul-2007 - France's largest independent drug company Servier has invested €40m in a new tablet producing factory in Russia to meet demand from the local market.
05-Jul-2007 - A UK firm has introduced a new piece of kit for pharma firms to test how the contents of their hard gel capsules can affect the strength and stability of the outer shell.
04-Jul-2007 - Italian firm Cosmo Pharmaceuticals has announced positive preliminary results from trials testing out a new formulation of an antibioticfor traveller's diarrhoea that makes use of the company's innovative MMX technology.
03-Jul-2007 - Irish firm Azur Pharma is the proud new owner of schizophrenia drug FazaClo (clozapine), sold off by pharma firm Avanir as it struggles to scrape together resources to fund development of its lead candidate, Zenvia (dextromethorphan, quinidine).
02-Jul-2007 - A new and improved extended-release treatment for schizophrenia has been granted marketing authorisation by the European Commission. Invega (paliperidone) is a once-daily formulation that will be marketed by J&J subsidiary, Janssen-Cilag.